These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36660663)

  • 1. MiR-202-3p inhibits the proliferation and metastasis of lung adenocarcinoma cells by targeting RRM2.
    Cao X; Xue F; Chen H; Shen L; Yuan X; Yu Y; Zong Y; Zhong L; Huang F
    Ann Transl Med; 2022 Dec; 10(24):1374. PubMed ID: 36660663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-582-3p targeting ribonucleotide reductase regulatory subunit M2 inhibits the tumorigenesis of hepatocellular carcinoma by regulating the Wnt/β-catenin signaling pathway.
    Xu H; Li B
    Bioengineered; 2022 May; 13(5):12876-12887. PubMed ID: 35609318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-200c-3p and miR-485-5p overexpression elevates cisplatin sensitivity and suppresses the malignant phenotypes of non-small cell lung cancer cells through targeting RRM2.
    Liu Y; Zhang Y; Li Q; Xu R; Huang N
    Thorac Cancer; 2022 Jul; 13(13):1974-1985. PubMed ID: 35599447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression.
    Huang H; Yang C; Zhang Q; Zhuo T; Li X; Li N; Zhu L; Luo C; Gan J; Wu Y
    Bioengineered; 2022 Mar; 13(3):4964-4977. PubMed ID: 35164653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical significance and mechanism of microRNA-22-3p targeting TP53 in lung adenocarcinoma.
    Lin R; Li GS; Gan XY; Peng JX; Feng Y; Wang LT; Zhang CY; Huang KY; Huang SH; Yang L; Kong JL; Zhou HF; Chen G; Huang WY
    Technol Health Care; 2023; 31(5):1691-1707. PubMed ID: 36970920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-140-3p represses the proliferation, migration, invasion and angiogenesis of lung adenocarcinoma cells via targeting TYMS (thymidylate synthetase).
    Wan S; Liu Z; Chen Y; Mai Z; Jiang M; Di Q; Sun B
    Bioengineered; 2021 Dec; 12(2):11959-11977. PubMed ID: 34818974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxymatrine induces anti-tumor response in cervical cancer by modulating circ_0008460/miR-197-3p/ribonucleotide reductase subunit M2 (RRM2).
    Li S; Zhang H; Jiao Y; Song X; Wei L; Liu X
    Bioengineered; 2022 May; 13(5):12912-12926. PubMed ID: 35609310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Biomarker
    Yang T; Si Q; Liu M; DU R; Ji L; Zhang X; Su J; Sun H; Wang L; Zhao C; Liu J; Ouyang S; Dai L
    Anticancer Res; 2023 Nov; 43(11):4923-4935. PubMed ID: 37909971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis Value of microRNA-3677-3p in Lung Adenocarcinoma and Its Regulatory Effect on Tumor Progression.
    Zhao J; Yu H; Han T; Zhu X
    Cancer Manag Res; 2021; 13():9261-9270. PubMed ID: 34955656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-490-3p Inhibits the Malignant Progression of Lung Adenocarcinoma.
    Li Z; Jiang D; Yang S
    Cancer Manag Res; 2020; 12():10975-10984. PubMed ID: 33154676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ-AASDH functions as the progression of early stage lung adenocarcinoma by targeting miR-140-3p to activate E2F7 expression.
    Wang Y; Wo Y; Lu T; Sun X; Liu A; Dong Y; Du W; Su W; Huang Z; Jiao W
    Transl Lung Cancer Res; 2021 Jan; 10(1):57-70. PubMed ID: 33569293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The LncRNA NEAT1 Accelerates Lung Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a Competitive Endogenous RNA.
    Xiong DD; Li ZY; Liang L; He RQ; Ma FC; Luo DZ; Hu XH; Chen G
    Cell Physiol Biochem; 2018; 48(3):905-918. PubMed ID: 30036873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of hsa-miR-30b-3p Inhibits the Oncogenicity of Lung Adenocarcinoma by Targeting the
    Li N; Li R; Song B; Ge H; Qu Y
    J Oncol; 2022; 2022():6883140. PubMed ID: 35646115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F8 exerts cancer-promoting effects by transcriptionally activating RRM2 and E2F8 knockdown synergizes with WEE1 inhibition in suppressing lung adenocarcinoma.
    Liu K; Wang L; Lou Z; Guo L; Xu Y; Qi H; Fang Z; Mei L; Chen X; Zhang X; Shao J; Xiang X
    Biochem Pharmacol; 2023 Dec; 218():115854. PubMed ID: 37863324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-133b inhibits cell proliferation, migration, and invasion of lung adenocarcinoma by targeting CDCA8.
    Hu C; Wu J; Wang L; Liu X; Da B; Liu Y; Huang L; Chen Q; Tong Y; Jiang Z
    Pathol Res Pract; 2021 Jul; 223():153459. PubMed ID: 33971546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-144-3p inhibits the proliferation, migration and invasion of lung adenocargen cancer cells by targeting COL11A1.
    Sun Y; Liu Z; Huang L; Shang Y
    J Chemother; 2021 Oct; 33(6):409-419. PubMed ID: 33845716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
    Sui MH; Zhang WW; Geng DM; Sun DJ
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of Ribonucleoside-diphosphate Reductase Subunit M2 in Lung Adenocarcinoma.
    Wang XJ; Huo YX; Yang PJ; Gao J; Hu WD
    Curr Gene Ther; 2024 Jun; ():. PubMed ID: 38920074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA LINC00511 promotes COL1A1-mediated proliferation and metastasis by sponging miR-126-5p/miR-218-5p in lung adenocarcinoma.
    Wang Y; Mei X; Song W; Wang C; Qiu X
    BMC Pulm Med; 2022 Jul; 22(1):272. PubMed ID: 35842617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RRM2 Regulated By LINC00667/miR-143-3p Signal Is Responsible For Non-Small Cell Lung Cancer Cell Progression.
    Yang Y; Li S; Cao J; Li Y; Hu H; Wu Z
    Onco Targets Ther; 2019; 12():9927-9939. PubMed ID: 31819489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.